Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bonella

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Frontiers in Medicine|May 22, 2023
Thoracic pain in patients with chronic interstitial lung disease-an underestimated symptomManuela J Scherer, Sandra Kampe, Jonas Fredebeul-Beverungen, et al.
Frontiers in Medicine|August 12, 2025
Correction: Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosisRaluca-Andreea Smǎrǎndescu, Marina-Ruxandra Oțelea, Eugenia Panaitescu, et al.
The European Respiratory Journal|July 2, 2016
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunityFrancesco Bonella, Marlies Wijsenbeek, Maria Molina-Molina, et al.
The European Respiratory Journal|July 10, 2019
Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trialsImre Noth, Marlies Wijsenbeek, Martin Kolb, et al.
The European Respiratory Journal|November 21, 2015
European IPF Patient Charter: unmet needs and a call to action for healthcare policymakersFrancesco Bonella, Marlies Wijsenbeek, Maria Molina-Molina, et al.
Respiratory Medicine|July 9, 2013
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseasesMiaotian Cai, Francesco Bonella, Xuan He, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2016
An Important Step Forward, but Still a Way to GoWim A Wuyts, Francesco Bonella, Ulrich Costabel, et al.
Journal of Clinical Medicine|February 11, 2023
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung DiseaseLutz B Jehn, Ulrich Costabel, Eda Boerner, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 14, 2024
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosisSara Lettieri, Francesco Bonella, Vincenzo Alfredo Marando, et al.
BMC Pulmonary Medicine|May 9, 2020
Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysisHanyu Shi, Dawei Yin, Francesco Bonella, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Frontiers in Medicine|May 22, 2023
Thoracic pain in patients with chronic interstitial lung disease-an underestimated symptomManuela J Scherer, Sandra Kampe, Jonas Fredebeul-Beverungen, et al.
Frontiers in Medicine|August 12, 2025
Correction: Serum concentrations of Krebs von den Lungen-6 as prognostic biomarker in patients with silicosisRaluca-Andreea Smǎrǎndescu, Marina-Ruxandra Oțelea, Eugenia Panaitescu, et al.
The European Respiratory Journal|July 2, 2016
European idiopathic pulmonary fibrosis Patient Charter: a missed opportunityFrancesco Bonella, Marlies Wijsenbeek, Maria Molina-Molina, et al.
The European Respiratory Journal|July 10, 2019
Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trialsImre Noth, Marlies Wijsenbeek, Martin Kolb, et al.
The European Respiratory Journal|November 21, 2015
European IPF Patient Charter: unmet needs and a call to action for healthcare policymakersFrancesco Bonella, Marlies Wijsenbeek, Maria Molina-Molina, et al.
Respiratory Medicine|July 9, 2013
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseasesMiaotian Cai, Francesco Bonella, Xuan He, et al.
American Journal of Respiratory and Critical Care Medicine|February 2, 2016
An Important Step Forward, but Still a Way to GoWim A Wuyts, Francesco Bonella, Ulrich Costabel, et al.
Journal of Clinical Medicine|February 11, 2023
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung DiseaseLutz B Jehn, Ulrich Costabel, Eda Boerner, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|August 14, 2024
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosisSara Lettieri, Francesco Bonella, Vincenzo Alfredo Marando, et al.
BMC Pulmonary Medicine|May 9, 2020
Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysisHanyu Shi, Dawei Yin, Francesco Bonella, et al.
Pageof 20